Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 7/20 | 0.36 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.36 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.36 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10110574 | 1.00 | ABCG2 (0.36) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL10110555 | 1.00 | ABCG2 (0.36) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL25877261 | 0.96 | ABCG2 (0.34) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL10110553 | 0.94 | ABCG2 (0.33) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL9916396 | 0.93 | ABCG2 (0.36) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL9916662 | 0.93 | ABCG2 (0.36) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL10110110 | 0.93 | ABCG2 (0.36) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL10110099 | 0.93 | ABCG2 (0.36) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL9916397 | 0.92 | ABCG2 (0.36) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL9916426 | 0.92 | ABCG2 (0.36) | ABCG2PAX8CYP1A1CYP1A2FYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9087997-B2 | Aromatic amine derivative and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2015-07-21 | — | — | US | disclosed |
| US-9087997-B2 | Aromatic amine derivative and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2015-07-21 | — | — | US | disclosed |
| US-8703304-B2 | Aromatic amine derivative and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2014-04-22 | — | — | US | disclosed |
| US-8703304-B2 | Aromatic amine derivative and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2014-04-22 | — | — | US | disclosed |
| US-20140061630-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-03-06 | — | — | US | disclosed |
| US-20140061630-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-03-06 | — | — | US | disclosed |
| US-20120161119-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-06-28 | — | — | US | disclosed |
| US-20120161119-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120161119-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE | TYR, TERF2, SAT1 | ABCG2 809/4885PAX8 1558/4885CYP1A1 757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.